Table 2.

Clinical background of patients with terminal heart failure.

Patient	Sex	Age	Cause of heart failure	NYHA	Assist	Other diseases	Tissue used for
1	M	65	Ischemic dilated cardiomyopathy	IIIA	No	ASD, atrial fibrillation and asthma	Proteomics IHC PCR
2	F	60	Restrictive cardiomyopathy, due to amyloidosis	IIIA	No	PAH, asthma, amyloidosis and myeloma	Proteomics IHC PCR
3	F	64	Idiopathic dilated cardiomyopathy	IIIB	No	PAH, valvular disease, atrial fibrillation, diabetes type II, hypertension, renal insufficiency, hypothyreosis and previous ovarian cancer	Proteomics IHC PCR
4	M	27	Idiopathic dilated cardiomyopathy	III	Yes	PAH, atrial fibrillation	Proteomics PCR
5	M	66	Idiopathic dilated cardiomyopathy	IIIA	Yes	PAH, previous stroke and diabetes type II	IHC PCR
6	M	67	Ischemic cardiomyopathy	IIIA	Yes	PAH, previous AMI, atrial fibrillation and renal insufficiency	IHC PCR
7	M	45	Hypertrophic cardiomyopathy	IIIB	No	PAH	IHC PCR
8	M	39	Ischemic cardiomyopathy	III	No	PAH, previous AMI, valvular disease, diabetes type I, mild retinopathy and nephropathy	PCR
9	M	66	Dilated cardiomyopathy due to amyloidosis	IIIB	No	Diabetes type II and PAH	PCR
10	M	50	Ischemic dilated cardiomyopathy	IIIA	No	Diabetes type II, hypertension, and previous stroke	PCR
11	M	61	Hypertrophic cardiomyopathy	III	No	Previous stroke, previous atrial fibrillation, previous Maze surgery, renal insufficiency, COPD	PCR

Table summarizes the clinical background of the included patients that underwent cardiac transplantation due to heart failure. F = female, M = Male, NYHA = New York Heart Association, PAH = Pulmonary Arterial Hypertension, AMI = Acute Myocardial Infarction, ASD = Atrial Septum Deficiency, COPD = Chronic Obstructive Pulmonary Disease, Assist = mechanical assist (i.e. LVAD / BiVAD), LVAD = Left Ventricular Assist Device, Proteomics = Global Quantitative proteomics, IHC = Immunohistochemistry, PCR = Polymerase chain reaction.